Seeking an inpatient hospitalist. Must be board certificed/eligable in hematology. For more information contact Carol Webb at cwebb2@kumc.edu.
Hematologic Malignancies and Cellular Therapeutics
School of Medicine > Internal Medicine > Divisions > HMCT > Cancer Site Specific Teams > MDS and Elderly Leukemia
Myelodysplastic Syndromes (MDS) and Elderly Leukemia
Cancer Site Specific Teams develop comprehensive quality cancer care service from screening to survivorship for patients with cancer.
Learn more about hematologic (blood) cancers:
- BMT (Blood and Marrow Transplant)
- Immunotherapy (new type of cancer research)
- Leukemia
- Lymphoma
- Myeloma
Clinical Trials
There are many clinical trials at the University of Kansas Cancer Center. Please select the links below to learn more.
Contact our Clinical Trial Nurse Navigator:
Phone: 913-945-7552
Email: CTNurseNav@kumc.edu
Featured Trial:
- Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome (MDS)
- PI: Abdulraheem Yacoub, MD
- NCT# 01772420- Click on the link to learn national information about this trial.
MDS/Elderly Leukemia Trials:
- MDS
- Leukemia, Other
- Leukemia, Not Specified
- Lymphoid Leukemia
- Myeloid and Monocytic Leukemia
- Clinical Trial Main Page
Support Groups
- Turning Point: Support for serious or chronic physical illness in the KC area
- Gilda's Club: Support for all cancers and stage
- Cancer Action: For programs and services of persons with cancer, their family, and friends
Last modified:
Aug 12, 2020